Open AccessPharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers
Author(s) -
Marta Boffito,
Akil Jackson,
Mohammed Lamorde,
David Back,
Victoria Watson,
J. Andrew Taylor,
Laura Waters,
David Asboe,
Brian Gazzard,
Anton Pozniak
Publication year - 2009
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3181b061d0
Subject(s) - efavirenz , etravirine , pharmacokinetics , cmax , medicine , confidence interval , area under the curve , reverse transcriptase inhibitor , pharmacology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , immunology
To assess the pharmacokinetics of etravirine once and twice daily without and with a preceding efavirenz intake period in healthy volunteers.